In vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells

Planta Medica

Volumn 77, Issue 7, 2011, Pages 711-717

  Van Goietsenoven, Gwendoline ^a   Mathieu, Véronique ^a   Andolfi, Anna ^c   Cimmino, Alessio ^c   Lefranc, Florence ^a,b   Kiss, Robert ^a   Evidente, Antonio ^c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

cancer; cytochalasins; cytostatic; cytotoxic; in vitro; quantitative videomicroscopy

Indexed keywords

CARBOPLATIN; CYTOCHALASIN; CYTOCHALASIN A; CYTOCHALASIN B; CYTOCHALASIN DERIVATIVE; CYTOCHALASIN F; CYTOCHALASIN H; CYTOCHALASIN T; CYTOCHALASIN V; CYTOCHALASIN Z2; CYTOCHALASIN Z3; DEOXAPHOMIN; DIHYDROCYTOCHALASIN B; ETOPOSIDE; HYDROXYL GROUP; MACROCYCLIC COMPOUND; PERHYDROISOINSOLYL 1 ONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL STIMULATION; COLORIMETRY; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOUSE; NONHUMAN; PROGNOSIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ASCOMYCOTA; CELL LINE, TUMOR; CYTOCHALASINS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 79955804759     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250523     Document Type: Article

References (35)

1. Carter S B. Effects of cytochalasins on mammalian cells. Nature 1967 213 261-264
2. Aldridge D C., Armstrong J J., Speake R N., Turner W B. The cytochalasins, a new class of biologically active mould metabolites. J Chem Soc Chem Commun 1967 3 26-27
3. Vurro M, Bottalico A, Capasso R, Evidente A. Cytochalasins from phytopatogenic Ascochyta and Phoma species. Upadahyay RK, Mukerji KG Toxins in Plants Disease Development and Evolving Biotechnology. New Delhi Oxford & IBH Publishing Co. 1997 127-147
4. Capasso R, Evidente A, Ritieni A, Randazo G, Vurro M, Bottalico A. Ascochalasin, a new cytochalasin from Ascochyta heteromorpha. J Nat Prod 1988 51 567-571
5. Capasso R, Evidente A, Randazo G, Ritieni A, Vurro M, Bottalico A, Logrieco A. Isolation of cytochalasins A and B from Ascochyta heteromorpha. J Nat Prod 1987 50 989-990 (Pubitemid 17158677)
6. Evidente A, Lanzetta R, Capasso R, Vurro M, Bottalico A. Cytochalasins U and V, two new cytochalasans, from Phoma exigua var. heteromorpha. Tetrahedron 1992 48 6317-6324
7. Evidente A, Capasso R, Vurro M, Bottalico A. Cytochalasin W, a new 24-oxa[14]cytochalasan from Phoma exigua var. heteromorpha. Nat Toxins 1996 4 53-57 (Pubitemid 26144961)
8. Capasso R, Evidente A, Vurro M. Cytochalasins from Phoma exigua var. heteromorpha. Phytochemistry 1991 30 3945-3950
9. Evidente A, Andolfi A, Vurro M, Zonno M C., Motta A. Cytochalasins Z1, Z2, and Z3, three 24-oxa[14]cytochalasans produced by Pyrenophora semeniperda. Phytochemistry 2002 60 45-53 (Pubitemid 34516839)
10. Evidente A, Andolfi A, Vurro M, Zonno M C., Motta A. Cytochalasins Z4, Z5, and Z6, three new 24-Oxa[14]cytochalasans produced by Phoma exigua var. heteromorpha. J Nat Prod 2003 66 1540-1544 (Pubitemid 38036702)
11. Thilly W G., Liber H L., Wogan G N. Toxicity and structure-activity relationships of cytochalasins. Tanenbaum SW Cytochalasins and Cell Biological Aspects. Amsterdam Elsevier North-Holland Biomedical Press 1978 53-64
12. Yahara I, Harada F, Sekita S, Yoshihira K, Natori S. Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro. J Cell Biol 1982 92 69-78 (Pubitemid 12138112)
13. Choi B H., Park J A., Kim K R., Lee G I., Lee Y T., Choe H, Ko S H., Kim M H., Seo Y H., Kwak Y G. Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents. Am J Physiol Cell Physiol 2005 289 C425-C436 (Pubitemid 41008889)
14. Goddette D W., Frieden C. Actin polymerization. The mechanism of action of cytochalasin D. J Biol Chem 1986 261 15974-15980 (Pubitemid 17202846)
15. Udagawa T, Yuan J, Panigrahy D, Chang Y H., Shah J, D'Amato R J. Cytochalasin E, an epoxide containing Aspergillus -derived fungal metabolite, inhibits angiogenesis and tumor growth. J Pharmacol Exp Ther 2000 294 421-427 (Pubitemid 30490811)
16. Mel'nik V. A Key to the fungi of the genus Ascochyta Lib. (Coelomycetes). Mel'nik VA, Braun U, Hagedorn G Mitteilungen von der Biologischen Bundesanstalt fr Land- und Forstwirtschaft Berlin-Dahlem, Heft 379. Berlin Parey Buchverlag 2000 1-192
17. Cimmino A, Andolfi A, Berestetskiy A, Evidente A. Production of phytotoxins by Phoma exigua var. exigua, a potential mycoherbicide against perennial thistles. J Agric Food Chem 2008 56 6304-6309
18. Bottalico A, Capasso R, Evidente A, Randazzo G, Vurro M. Cytochalasins: structure activity relationships. Phytochemistry 1990 29 93-96
19. Bruyre C, Lonez C, Duray A, Cludts S, Ruysschaert J M., Saussez S, Yeaton P, Kiss R, Mijatovic T. Considering temozolomide as a novel potential treatment for oesophageal cancer. Cancer, in press[nl]
20. Ingrassia L, Lefranc F, Dewelle J, Pottier L, Mathieu V, Spiegl-Kreinecker S, Sauvage S, El Yazidi M, Dehoux M, Berger W, Van Quaquebeke E, Kiss R. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. J Med Chem 2009 52 1100-1114
21. Mathieu V, Pirker C, Martin de Lassalle E, Vernier M, Mijatovic T, De Neve N, Gaussin J-F, Dehoux M, Lefranc F, Berger W, Kiss R. The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment. J Cell Mol Med 2009 13 3960-3972
22. Mijatovic T, Mathieu V, Gaussin J-F, De Nve N, Ribaucour F, Van Quaquebeke E, Dumont P, Darro F, Kiss R. Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 2006 8 402-412 (Pubitemid 43830747)
23. Mathieu V, Le Mercier M, De Neve N, Sauvage S, Gras T, Roland I, Lefranc F, Kiss R. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J Invest Dermatol 2007 127 2399-2410 (Pubitemid 47619747)
24. Hayot C, Debeir O, Van Ham P, Van Damme M, Kiss R, Decaestecker C. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol Appl Pharmacol 2006 211 30-40 (Pubitemid 43152095)
25. Stehn J R., Schevzov G, O'Neill G M., Gunning P W. Specialisation of the tropomyosin composition of actin filaments provides new potential targets for chemotherapy. Curr Cancer Drug Targets 2006 6 245-256 (Pubitemid 43764743)
26. Decaestecker C, Debeir O, Van Ham P, Kiss R. Can anti-migratory drugs be screened in vitro ? A review of 2D and 3D assays for the quantitative analysis of cell migration. Med Res Rev 2007 27 149-176 (Pubitemid 46281145)
27. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 2009 16 66-93
28. Shen Z, Yang Q, You Q. Researches toward potassium channels on tumor progressions. Curr Top Med Chem 2009 9 322-329
29. Wulff H, Castle N A., Pardo L A. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 2009 8 982-1001
30. Prevarskaya N, Skryma R, Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol Med 2010 16 107-121
31. Negulyaev Y A., Khaitlina S Y., Hinssen H, Shumilina E V., Vedernikova E A. Sodium channel activity in leukemia cells is directly controlled by actin polymerization. J Biol Chem 2000 275 40933-40937 (Pubitemid 32054916)
32. Wang Z, Eldstrom J R., Jantzi J, Moore E D., Fedida D. Increased focal Kv4.2 channel expression at the plasma membrane is the result of actin depolymerization. Am J Physiol Heart Circ Physiol 2004 286 H749-H759 (Pubitemid 38140358)
33. Staruschenko A, Negulyaev Y A., Moracheskaya E A. Actin cytoskeleton disassembly affects conductive properties of stretch-activated cation channels in leukaemia cells. Biochim Biophys Acta 2005 1669 53-60 (Pubitemid 40544521)
34. Bonnet S, Archer S L., Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee C T., Lopaschuk G D., Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter C J., Andrade M A., Thebaud B, Michelakis E D. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007 11 37-51 (Pubitemid 46054520)
35. Bielanska J, Hernandez-Losa J, Perez-Verdaguer M, Moline T, Somoza R, Ramon Y, Cajal S, Condom E, Ferreres J C., Felipe A. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr Cancer Drug Targets 2009 9 904-914